Dannex Ayrton Starwin Plc (GHSE:DASPHARMA)
0.4100
0.00 (0.00%)
At close: Jun 23, 2026
Dannex Ayrton Starwin Company Description
Dannex Ayrton Starwin Plc engages in the manufacturing, importing, and sale of pharmaceutical products in Ghana.
The company offers analgesics, hematinic, anti-tussive, dermatological products, anti-convulsing and anti-asthmatics in forms of tablets, capsules, powders, ointments, and chemicals and disinfectants, as well as liquids, such as syrups and suspensions.
It provides its products under Durol, Virol, Samalin, Teeder, Koffex, ORS, Rapinol, Asmadrin and Milk of Magnesia brand names.
Dannex Ayrton Starwin Plc was founded in 1964 and is based in Accra, Ghana.
Dannex Ayrton Starwin Plc
| Country | Ghana |
| Founded | 1964 |
| Industry | Pharmaceutical Preparations |
| Employees | 83 |
| CEO | Daniel Kwabena Kissi |
Contact Details
Address: No. 5 Dadeban Road Accra Ghana | |
| Phone | 233 2 4431 5261 |
| Website | dasplcgh.com |
Stock Details
| Ticker Symbol | DASPHARMA |
| Exchange | Ghana Stock Exchange |
| Reporting Currency | GHS |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Daniel Kwabena Kissi | Chief Executive Officer |
| Henry Ocansey | Chief Financial Officer |